Skip to content
In English |
En español
National Cancer Institute
at the National Institutes of Health
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
Email This Document
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
LiveHelp online chat
Popular Resources
Help Using the NCI Clinical Trials Search Form
Learn About Clinical Trials
About NCI's List of Cancer Clinical Trials
NCI Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-12 of 12 for your search:
Drug:
zinostatin
Find trials that include:
Any drugs shown
Trial Status:
Closed
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Phase II-III Trial of Neocarzinostatin vs m-AMSA or ADR in Advanced Hepatocellular Carcinoma
Phase:
Phase III, Phase II
Type:
Treatment
Status:
Completed
Age:
no age specified
Sponsor:
NCI
Protocol IDs:
EST-1280
2.
Phase III Chemotherapy with PALA, AMSA, VM-26, and NCS as Single Agents in Small Cell Lung Cancer
Phase:
Phase III
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
NCI
Protocol IDs:
EST-2579
3.
Phase II Chemotherapy with Neocarzinostatin for Advanced Metastatic Urothelial Bladder Carcinoma
Phase:
Phase II
Type:
Treatment
Status:
Completed
Age:
no age specified
Sponsor:
Protocol IDs:
MSKCC-7757
4.
Phase II Chemotherapy with Neocarzinostatin for Acute Lymphocytic or Acute Nonlymphocytic Leukemia in Children
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
18 and under
Sponsor:
NCI
Protocol IDs:
POG-7831
, MDAR-319
5.
Phase II Hepatic Infusion Therapy with FUDR, MTX/TDR, NZS, ADR, BCNU, DCM for Primary or Metastatic Liver Cancer
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
under 70
Sponsor:
Protocol IDs:
DFCI-76050
6.
Phase II Chemotherapy with Neocarzinostatin for Solid Tumors and Leukemias
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
Protocol IDs:
DFCI-77002
7.
Phase II Chemotherapy with Neocarzinostatin for Acute Leukemia and for Various Solid Tumors
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
NCI
Protocol IDs:
CLB-0704
8.
Phase II Master Protocol and Trials with AMSA and Neocarzinostatin for non-Small Cell Lung Carcinoma
Phase:
Phase II
Type:
Treatment
Status:
Completed
Age:
under 75
Sponsor:
NCI
Protocol IDs:
EST-1579
9.
Phase II Master Protocol with MeCCNU, MeCCNU/BCG, MeCCNU/HU/DTIC, BCG, ACT-D/HU/DTIC, CLZ, NZS, MGBG, or DBD Therapy for Metastatic Melanoma
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
NCI
Protocol IDs:
EST-1675
10.
Phase II Chemotherapy with NZS for Chronic and Acute Leukemias, Lymphoma, and Liver, Renal, and Bladder Carcinomas
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
Protocol IDs:
MDA-DT-7534A
11.
Phase I Chemotherapy with Neocarzinostatin for Solid Tumors and Hematologic Malignancies
Phase:
Phase I
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
Protocol IDs:
MDA-DT-7534
12.
Chemotherapy with VP-16213 plus Neocarzinostatin for Adult Hepatocellular Carcinoma
Phase:
No phase specified
Type:
Treatment
Status:
Closed
Age:
15 to 70
Sponsor:
Protocol IDs:
UMCC-7809
Select All on Page
Help with Results
We Can Answer Your Questions
1-800-4-CANCER
LiveHelp Online Chat
NCI Home
Contact Us
Policies
Accessibility
Viewing Files
FOIA
Site Help
Site Map
Other Versions of this Site:
Mobile
|
Español
Follow Us:
Twitter
YouTube
Facebook
RSS
NIH…Turning Discovery Into Health
®
Mobile | Español
Mobile | Español
